1. S.B. Hanauer, Inflammatory bowel disease, in: “Cecil Textbook of Medicine,” 19th ed., W.B.Saunders Company, Philadelphia (1992).
2. J. Williamson, R.W.W. Paterson, D.D.M. McGavin, M.K. Jasani, J.A. Boyle, and W.M. Doig,Posterior subcapsular cataracts and glaucoma associated with long-term corticosteroid therapy, Br J Ophthalmol 53:361(1969).
3. R.C. Tripathi, B.S. Kirschner, M. Kipp, B.J. Tripathi, D. Slotwiner, N.S.C. Borisuth, T.Karrison, and J.T. Ernest, Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure, Gastroenter. 102:1957(1992).
4. R.C. Tripathi, M. Kipp, B.J. Tripathi, B.S. Kirschner, N.S.C. Borisuth, and J.T. Ernest, Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease, Lens and Eye Toxicity Res. 9:469(1992).
5. S.J. Crews, Posterior subcapsular lens opacities in patients on long-term corticosteroid therapy, Br Med J. 5346:1644(1963).